Drug screening for human genetic diseases using iPSC models

Human Molecular Genetics
Matthew S ElittPaul J Tesar

Abstract

Induced pluripotent stem cells (iPSCs) enable the generation of previously unattainable, scalable quantities of disease-relevant tissues from patients suffering from essentially any genetic disorder. This cellular material has proven instrumental for drug screening efforts on these disorders, and has facilitated the identification of novel therapeutics for patients. Here we will review the foundational technologies that have enabled iPSCs, the power and limitations of iPSC-based compound screens along with screening guidelines, and recent examples of screening efforts. Additionally we will provide a brief commentary on the future scientific roadmap using pluripotent- and 3D organoid-based, combinatorial approaches.

References

Nov 6, 1975·Nature·V E PapaioannouM J Evans
Oct 1, 1974·The Journal of Experimental Medicine·R L Brinster
May 1, 1974·Journal of the National Cancer Institute·J Jami, E Ritz
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R Martin
Feb 27, 1997·Nature·I WilmutK H Campbell
Nov 6, 1998·Science·J A ThomsonJ M Jones
Dec 10, 1998·Trends in Microbiology·S Rottem, Y Naot
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Mar 17, 2001·Nature Reviews. Genetics·J A Robertson
Apr 1, 1962·Developmental Biology·J B GURDON
Feb 12, 2005·Reproductive Biomedicine Online·Y VerlinskyA Kuliev
Mar 15, 2006·Nature Reviews. Genetics·Ryan R BrinkmanMark E Samuels
Jun 29, 2007·Nature·I Gabrielle M BronsLudovic Vallier
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Jul 4, 2009·Reproductive Biomedicine Online·Jonathan C NiclisDavid S Cram
Oct 3, 2009·Stem Cells and Development·Xing YanGeorge T-J Huang
Jun 10, 2010·Nature Reviews. Drug Discovery·M Miles BraunTimothy R Coté
Jun 11, 2010·Nature·Xonia Carvajal-VergaraIhor R Lemischka
Jul 14, 2010·Cell Stem Cell·Judith StaerkRudolf Jaenisch
Jul 21, 2010·Nature·K KimG Q Daley
Jul 28, 2010·The New England Journal of Medicine·Alessandra MorettiKarl-Ludwig Laugwitz
Jan 18, 2011·Nature·Ilanit ItzhakiLior Gepstein

❮ Previous
Next ❯

Citations

Mar 16, 2019·Annals of the New York Academy of Sciences·M Catarina Silva, Stephen J Haggarty
May 7, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Davis M Aasen, M Natalia Vergara
Oct 22, 2019·Glia·Konstantina ChanoumidouTanja Kuhlmann
Oct 9, 2019·Proceedings of the National Academy of Sciences of the United States of America·Lu LiVassilios Papadopoulos
Aug 28, 2020·Frontiers in Cellular Neuroscience·Daniela Espinosa-HoyosKrystyn J Van Vliet
Jan 9, 2019·Frontiers in Cell and Developmental Biology·Silvia Crasto, Elisa Di Pasquale
Aug 9, 2019·Molecular Psychiatry·Jay PenneyLi-Huei Tsai
Aug 10, 2019·World Journal of Stem Cells·José BragançaJoão Miguel Almeida Santos
May 3, 2019·The New England Journal of Medicine·Helen M Blau, George Q Daley
Dec 15, 2019·Nature Reviews. Drug Discovery·Erik TambuyzerMarco Prunotto
Jun 13, 2020·Frontiers in Bioengineering and Biotechnology·Marta Mazzola, Elisa Di Pasquale
Sep 29, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Alexios A Panoutsopoulos
Nov 17, 2020·Tissue Engineering. Part a·Shannon K O'ConnorFarshid Guilak
Sep 21, 2019·Neuropharmacology·Zane R LybrandJenny Hsieh
Jan 12, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gabriella MacDougallOrnit Chiba-Falek
Dec 31, 2020·International Journal of Molecular Sciences·Ekaterina S PotekhinaDmitry S Bilan
Feb 13, 2021·International Journal of Molecular Sciences·Li-Fen HuangChi-Hung Huang
Feb 16, 2021·Frontiers in Cardiovascular Medicine·Parisa K KargaranTamas Kozicz
Feb 4, 2021·International Journal of Molecular Sciences·Lu Qian, Julia Tcw
Mar 10, 2021·European Heart Journal·Massimiliano GnecchiPeter J Schwartz
Feb 11, 2019·Journal of Bioscience and Bioengineering·Kei YoshidaRyuji Kato
Mar 9, 2021·Frontiers in Immunology·Isabelle SerrCarolin Daniel
Aug 7, 2019·Current Opinion in Biotechnology·Connor Wiegand, Ipsita Banerjee
Jan 14, 2020·IScience·Satoshi KozawaThomas N Sato
Apr 4, 2021·International Journal of Molecular Sciences·Sonia BalestriAntonella Ragnini-Wilson
Oct 22, 2020·Seminars in Cell & Developmental Biology·Sabah Mozafari, Anne Baron-Van Evercooren
May 1, 2021·International Journal of Molecular Sciences·Gabriele BonaventuraSebastiano Cavallaro
Jun 3, 2021·Biomedicines·Magali SeguretJean-Sébastien Hulot
May 20, 2021·Current Opinion in Neurobiology·Peter James Michael Deans, Kristen J Brennand
Jun 16, 2021·Brain : a Journal of Neurology·Steven J MiddletonDavid L Bennett
Jul 1, 2021·Nature Reviews. Urology·Lu Li, Vassilios Papadopoulos
Jun 21, 2020·Drug Discovery Today·Sean LinKamyar Hadian
Jul 10, 2021·Reviews in Endocrine & Metabolic Disorders·Rubén EscribáÁngel Raya
Jul 25, 2021·International Journal of Molecular Sciences·Cameron L McKnightAnn E Frazier
Aug 10, 2021·The Journal of Allergy and Clinical Immunology·Yanyan LuoJörg Scheffel
Nov 3, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Araceli Rivera-OrdazLorenza Lazzari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Todd C McDevitt
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
K Sue O'Shea, Melvin G McInnis
Current Opinion in Genetics & Development
Tamer T Onder, George Q Daley
© 2022 Meta ULC. All rights reserved